A Nine-Gene Expression Signature Distinguished a Patient with Chronic Lymphocytic Leukemia Who Underwent Prolonged

Luca Emanuele Bossi1, Cassandra Palumbo1, Alessandra Trojani1

  • 1Department of Hematology and Oncology ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.

PubMed

Insights

Fasting and a vegetarian diet influenced absolute lymphocyte count (ALC) fluctuations in a Chronic Lymphocytic Leukemia (CLL) patient. A unique nine-gene signature was identified, potentially linked to disease course.

Area of Science:

  • Oncology
  • Immunology
  • Genetics

Background:

  • Investigated continuous deep fluctuations in absolute lymphocyte count (ALC) in an untreated Chronic Lymphocytic Leukemia (CLL) patient.
  • The patient followed a vegetarian/fruitarian diet and practiced prolonged annual fasting (4-39 days).

Purpose of the Study:

  • To investigate the causes of ALC fluctuations in an untreated CLL patient with a favorable prognosis.
  • To analyze whole transcriptome profiling of peripheral blood CD19+ cells from the patient during nutritional and fasting periods versus controls.

Main Methods:

  • Whole transcriptome profiling of peripheral blood CD19+ cells using Affymetrix Human Clariom™ D Pico Assay.
  • Comparison of 20 time-points from the fasting patient against single time-points from five other untreated CLL patients on varied diets.
  • Statistical analysis for differential gene expression and sample clustering.

Main Results:

  • Recurring ALC fluctuations observed in the fasting patient, with counts halving 4-6 weeks post-fasting.
  • Nine genes were statistically differentially expressed between the fasting patient and controls.
  • Clustering analysis showed distinct separation of the fasting patient's samples from controls.

Conclusions:

  • A nine-gene expression signature distinguishes an untreated CLL patient practicing prolonged fasting from those on varied diets.
  • This signature may play a role in sustaining lymphocytosis and the favorable disease course.
  • Further research on patient #1 could elucidate the role of fasting and the gene signature in CLL management.